Live feed07:30:00·371dPRReleasevia QuantisnowVaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation TechnologyByQuantisnow·Wall Street's wire, on your screen.VXRT· Vaxart IncHealth Care
